BioCentury | Mar 19, 2019
Company News

Management tracks: Medicines Co., Mallinckrodt, ArQule

...NASDAQ:SLS). Ascentage is developing small molecules for cancer, HBV and age-related diseases. Gastrointestinal disease company RDD Pharma Ltd....
BioCentury | Jun 5, 2018
Company News

Management tracks: Sarepta, Gilead

...chief technical officer. She was SVP of process development at Amgen Inc. (NASDAQ:AMGN). Gastrointestinal company RDD Pharma Ltd....
BioCentury | May 30, 2016
Clinical News

Intra-anal nifedipine: Phase III started

...reference data on safety and efficacy from the scientific literature or from previously approved products. RDD Pharma Ltd....
BioCentury | Aug 27, 2012
Finance

ECG for the brain

...medical device play SMT Research and Development Ltd. ; and intra-anal drug delivery company RDD Pharma Ltd. ...
Items per page:
1 - 4 of 4
BioCentury | Mar 19, 2019
Company News

Management tracks: Medicines Co., Mallinckrodt, ArQule

...NASDAQ:SLS). Ascentage is developing small molecules for cancer, HBV and age-related diseases. Gastrointestinal disease company RDD Pharma Ltd....
BioCentury | Jun 5, 2018
Company News

Management tracks: Sarepta, Gilead

...chief technical officer. She was SVP of process development at Amgen Inc. (NASDAQ:AMGN). Gastrointestinal company RDD Pharma Ltd....
BioCentury | May 30, 2016
Clinical News

Intra-anal nifedipine: Phase III started

...reference data on safety and efficacy from the scientific literature or from previously approved products. RDD Pharma Ltd....
BioCentury | Aug 27, 2012
Finance

ECG for the brain

...medical device play SMT Research and Development Ltd. ; and intra-anal drug delivery company RDD Pharma Ltd. ...
Items per page:
1 - 4 of 4